Position in MRNA
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,756,941
+$798,551 QoQ
Shares Held
39,368
+2.1% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#196
of 758 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $117,820,260 across 121 Biotechnology names. MRNA ranks #8 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
45,980 | $22,839,645 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,063 | $11,263,003 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
30,242 | $9,103,749 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
40,460 | $7,577,348 | |
| 5 | INSM |
INSMED Inc
|
48,273 | $5,146,867 | |
| 6 | INCY |
Incyte Corp
|
29,027 | $3,290,500 | |
| 7 | RPRX |
Royalty Pharma plc
|
55,752 | $3,126,014 | |
| 8 | MRNA |
Moderna, Inc.
This page
|
39,368 | $2,756,941 |
All Filings in MRNA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,756,941 | 39,368 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $1,958,390 | 38,551 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $894,785 | 30,342 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $706,889 | 27,367 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $852,448 | 30,897 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,287,430 | 45,412 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $1,861,536 | 44,770 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $3,019,646 | 45,184 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,233,550 | 44,072 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,737,551 | 44,459 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,217,575 | 42,409 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $4,123,336 | 39,920 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $4,739,715 | 39,010 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $6,548,497 | 42,639 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $8,153,311 | 45,392 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $4,719,712 | 39,913 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $4,372,067 | 30,606 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $10,027,254 | 58,210 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $15,545,607 | 61,208 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $21,638,368 | 56,224 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $9,300,038 | 39,578 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,933,083 | 30,035 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $3,091,685 | 29,594 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,104,741 | 29,749 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,794,797 | 27,952 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||